These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 11778266)
1. [Bronchogenic carcinoma and antiangiogenic therapy]. Qi X; Rao W Zhonghua Jie He He Hu Xi Za Zhi; 2000 Aug; 23(8):492-4. PubMed ID: 11778266 [No Abstract] [Full Text] [Related]
2. Advances in the use of angiogenesis inhibitors in cancer. Pinedo HM Cancer J; 2001; 7 Suppl 3():S107-8. PubMed ID: 11779080 [No Abstract] [Full Text] [Related]
3. Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats. Roman CD; Choy H; Nanney L; Riordan C; Parman K; Johnson D; Beauchamp RD J Surg Res; 2002 Jun; 105(1):43-7. PubMed ID: 12069500 [TBL] [Abstract][Full Text] [Related]
4. [Neoplasms and angiogenesis]. Lewy-Trenda I Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576 [TBL] [Abstract][Full Text] [Related]
7. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors. Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor in monitoring therapy of hepatic haemangioendothelioma. Szymik-Kantorowicz S; Partyka L; Dembinska-Kiec A; Zdzienicka A Med Pediatr Oncol; 2003 Mar; 40(3):196-7. PubMed ID: 12518353 [No Abstract] [Full Text] [Related]
9. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules. Zachary I IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611 [TBL] [Abstract][Full Text] [Related]
10. Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer. Blackhall FH; Shepherd FA Hematol Oncol Clin North Am; 2004 Oct; 18(5):1121-41, ix. PubMed ID: 15474338 [TBL] [Abstract][Full Text] [Related]
11. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma]. Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105 [TBL] [Abstract][Full Text] [Related]
12. A targeted approach for antiangiogenic therapy of metastatic human colon cancer. Ellis LM Am Surg; 2003 Jan; 69(1):3-10. PubMed ID: 12575772 [TBL] [Abstract][Full Text] [Related]
13. Molecular control of physiological skin angiogenesis. Odorisio T; Failla CM; Zambruno G Eur J Dermatol; 2002; 12(6):VII-X. PubMed ID: 12506892 [No Abstract] [Full Text] [Related]
14. Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells. Li X; Liu X; Wang J; Wang Z; Jiang W; Reed E; Zhang Y; Liu Y; Li QQ Anticancer Res; 2003; 23(3B):2481-7. PubMed ID: 12894531 [TBL] [Abstract][Full Text] [Related]
15. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression. Li D; Williams JI; Pietras RJ Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639 [TBL] [Abstract][Full Text] [Related]